These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37638129)

  • 1. Adamantyl-ureas with pyrazoles substituted by fluoroalkanes as soluble epoxide hydrolase inhibitors.
    Burmistrov VV; Morisseau C; Shkineva TK; Danilov DV; Gladkikh B; Butov GM; Fayzullin RR; Dutova TY; Hammock BD; Dalinger IL
    J Fluor Chem; 2023 Feb; 266():. PubMed ID: 37638129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoroaromatic fragments on 1,3-disubstituted ureas enhance soluble epoxide hydrolase inhibition.
    Burmistrov V; Morisseau C; D'yachenko V; Rybakov VB; Butov GM; Hammock BD
    J Fluor Chem; 2019 Apr; 220():48-53. PubMed ID: 32132741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symmetric adamantyl-diureas as soluble epoxide hydrolase inhibitors.
    Burmistrov V; Morisseau C; Lee KS; Shihadih DS; Harris TR; Butov GM; Hammock BD
    Bioorg Med Chem Lett; 2014 May; 24(9):2193-7. PubMed ID: 24685540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,3-Disubstituted and 1,3,3-trisubstituted adamantyl-ureas with isoxazole as soluble epoxide hydrolase inhibitors.
    Burmistrov V; Morisseau C; Danilov D; Harris TR; Dalinger I; Vatsadze I; Shkineva T; Butov GM; Hammock BD
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5514-9. PubMed ID: 26520661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adamantyl thioureas as soluble epoxide hydrolase inhibitors.
    Burmistrov V; Morisseau C; Pitushkin D; Karlov D; Fayzullin RR; Butov GM; Hammock BD
    Bioorg Med Chem Lett; 2018 Jul; 28(13):2302-2313. PubMed ID: 29803731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioisosteric substitution of adamantane with bicyclic lipophilic groups improves water solubility of human soluble epoxide hydrolase inhibitors.
    Burmistrov V; Morisseau C; Karlov D; Pitushkin D; Vernigora A; Rasskazova E; Butov GM; Hammock BD
    Bioorg Med Chem Lett; 2020 Sep; 30(18):127430. PubMed ID: 32736212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo metabolism of N-adamantyl substituted urea-based soluble epoxide hydrolase inhibitors.
    Liu JY; Tsai HJ; Morisseau C; Lango J; Hwang SH; Watanabe T; Kim IH; Hammock BD
    Biochem Pharmacol; 2015 Dec; 98(4):718-31. PubMed ID: 26494425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of adamantane alterations on soluble epoxide hydrolase inhibition potency, physical properties and metabolic stability.
    Burmistrov V; Morisseau C; Harris TR; Butov G; Hammock BD
    Bioorg Chem; 2018 Feb; 76():510-527. PubMed ID: 29310082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorine and chlorine substituted adamantyl-urea as molecular tools for inhibition of human soluble epoxide hydrolase with picomolar efficacy.
    Burmistrov VV; Morisseau C; Danilov DV; Gladkikh BP; D'yachenko VS; Zefirov NA; Zefirova ON; Butov GM; Hammock BD
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2274797. PubMed ID: 37975322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the size of the lipophilic unit of the soluble epoxide hydrolase inhibitors.
    Codony S; Valverde E; Leiva R; Brea J; Isabel Loza M; Morisseau C; Hammock BD; Vázquez S
    Bioorg Med Chem; 2019 Oct; 27(20):115078. PubMed ID: 31488357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substituted adamantyl-urea inhibitors of the soluble epoxide hydrolase dilate mesenteric resistance vessels.
    Olearczyk JJ; Field MB; Kim IH; Morisseau C; Hammock BD; Imig JD
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1307-14. PubMed ID: 16772540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Properties of 1,3-Disubstituted Ureas Containing (Adamantan-1-yl)(phenyl)methyl Fragment Based on One-Pot Direct Adamantane Moiety Inclusion.
    D'yachenko V; Danilov D; Kuznetsov Y; Moiseev S; Mokhov V; Burmistrov V; Butov G
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imidazolidine-2,4,5- and pirimidine-2,4,6-triones - New primary pharmacophore for soluble epoxide hydrolase inhibitors with enhanced water solubility.
    Burmistrov V; Morisseau C; D'yachenko V; Karlov D; Butov GM; Hammock BD
    Bioorg Med Chem Lett; 2020 Feb; 30(3):126908. PubMed ID: 31870649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 5-substituted piperazine as a novel secondary pharmacophore greatly improving the physical properties of urea-based inhibitors of soluble epoxide hydrolase.
    Li HY; Jin Y; Morisseau C; Hammock BD; Long YQ
    Bioorg Med Chem; 2006 Oct; 14(19):6586-92. PubMed ID: 16784862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships of substituted oxyoxalamides as inhibitors of the human soluble epoxide hydrolase.
    Kim IH; Lee IH; Nishiwaki H; Hammock BD; Nishi K
    Bioorg Med Chem; 2014 Feb; 22(3):1163-75. PubMed ID: 24433964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of amide-based inhibitors of soluble epoxide hydrolase with improved water solubility.
    Kim IH; Heirtzler FR; Morisseau C; Nishi K; Tsai HJ; Hammock BD
    J Med Chem; 2005 May; 48(10):3621-9. PubMed ID: 15887969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ureas derived from camphor and fenchone reveal enantiomeric preference of human soluble epoxide hydrolase.
    Burmistrov V; Morisseau C; Pitushkin D; Fayzullin RR; Karlov D; Vernigora A; Kuznetsov Y; Abbas SMH; Butov GM; Hammock BD
    Results Chem; 2022 Jan; 4():. PubMed ID: 37601415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Oxaadamant-1-yl Ureas as Soluble Epoxide Hydrolase Inhibitors:
    Codony S; Pujol E; Pizarro J; Feixas F; Valverde E; Loza MI; Brea JM; Saez E; Oyarzabal J; Pineda-Lucena A; Pérez B; Pérez C; Rodríguez-Franco MI; Leiva R; Osuna S; Morisseau C; Hammock BD; Vázquez-Carrera M; Vázquez S
    J Med Chem; 2020 Sep; 63(17):9237-9257. PubMed ID: 32787085
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs.
    Tsai HJ; Hwang SH; Morisseau C; Yang J; Jones PD; Kasagami T; Kim IH; Hammock BD
    Eur J Pharm Sci; 2010 Jun; 40(3):222-38. PubMed ID: 20359531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substituted phenyl groups improve the pharmacokinetic profile and anti-inflammatory effect of urea-based soluble epoxide hydrolase inhibitors in murine models.
    Liu JY; Lin YP; Qiu H; Morisseau C; Rose TE; Hwang SH; Chiamvimonvat N; Hammock BD
    Eur J Pharm Sci; 2013 Mar; 48(4-5):619-27. PubMed ID: 23291046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.